|
Drugmakers Could Face FCPA Investigations Due to Questionable Indian Drug Approvals
An Indian parliamentary report alleging inappropriate relationships between drug manufacturers and Indian regulators, along with unlawful drug approvals, could trigger U.S. government investigations, legal experts say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives